Situation Awareness
Situation Awareness: Cautious — breadth thin but broadening fast. Equity futures point to a higher open as the tape looks to build on Monday’s record-setting session, with the twin tailwinds of falling crude (WTI -2.3% to ~$87.42) and retreating Treasury yields (10-yr -5 bps to 5.26%) finally giving the broader market room to breathe after a punishing September of rate pressure and narrow leadership. SPY/QQQ/IWM cash levels are data-unavailable this morning, so lean on futures: S&P 500 futures +38 to 7,865, Nasdaq futures +192 to 31,510, Dow futures +363 to 51,921. Trade mode: selective and opportunistic — participate on confirmed broadening, but respect that only a quarter of names clear their intermediate trend. Today’s calling cards are the 8:30 ET August Trade Balance, a $58 bln 3-yr note auction at 13:00 ET, and STZ earnings after the close. Regime context — 23.93% of stocks trade above their 40-day SMA, and the 4% Bull/Bear gauge shows 215 bulls vs. 161 bears. The 5-day trend turned decisively up, with % above 20 SMA jumping to 44% from 29% — a +15pp surge signaling early, real broadening after a seven-week equal-weight losing streak.
SIP: GMAB VEEA BEAT CWH
- What’s working: the Continuation/2LYNCH scan is rich at 22 signals — healthy breadth — led by medical and software names; Reversal is dry at just 1 (SWKS).
- Leading sectors (live trending data unavailable — market closed): signal clustering points to MEDICAL (WAT, IDXX, TMO, MTD), SOFTWARE (SHOP, TEAM), and ELECTRONICS/MACHINERY as the day’s momentum pockets.
- Key event: $58 bln 3-yr Treasury auction at 13:00 ET — demand sets the tone for whether the yield relief holds.
- Market read: Monday broke the recent pattern — mega-caps led AND the equal-weight S&P caught up (+0.5%), with 10 of 11 sectors green. That participation shift is the single most important tell for today.
- DEP watchlist: no Delayed 9M signals today — stand down on that setup.
- SIPS: SHOP ($160.11, +5.8%), TEAM ($196.65, +4.7%), WAT ($440.12, +3.5%) as continuation swing candidates.
Today’s Market Narrative
The setup this morning is the cleanest it has been in weeks. After Monday’s close — Nasdaq Composite +1.1% to fresh record highs, S&P 500 +0.7% (finishing less than half a percent below its record), Dow +0.2%, Russell 2000 +0.5% — futures are extending the advance. The reason is simple: the two forces that have been strangling the broad market are both easing at once. Crude oil is down roughly 2.3% toward $87.42 on reports of increased flows out of the Middle East, and the 10-year yield has backed off five basis points to 5.26% after climbing to a fresh 2026 high of 5.31% Monday.
What makes this more than a relief bounce is the broadening. For most of September, index-level gains were a mega-cap and semiconductor mirage — the equal-weight S&P 500 fell 3.8% on the month while headline indices masked it. Monday snapped that: the Equal-Weight S&P recovered from an early decline to finish +0.5%, nearly matching the cap-weighted index, ending a seven-week losing streak. That shift is corroborated by our own breadth gauge, where the share of stocks above their 20-day SMA leapt from 29% to 44% in a single session.
Leadership remains tech-anchored but is no longer exclusively so. Meta (+1.9% to 741.90) continued its Muse AI-fueled run, NVIDIA added 2.1% to 238.90, and TSM hit fresh 52-week highs at 485.91 on Terafab chatter. This morning the gappers tell a diversifying story — OPCH +19.8% on the McKesson/CD&R buyout at $32.05/share, insurance broker AJG +4.0%, GRAL +3.2% on cancer-screening data, and ZS +3.1% reaffirming guidance at its investor day.
Overseas is supportive. Japan’s Nikkei climbed 1.1% to a three-month high on chip-equipment strength; Hang Seng +1.0% on tech and biotech; Europe’s STOXX 600 +0.7% despite a jaw-dropping Germany factory orders print (-10.6% m/m vs. -0.9% expected) and persistent French fiscal anxiety. The weak European data isn’t spooking equities — it’s reinforcing the bid for bonds that is relieving U.S. rate pressure.
Macro & Policy
The macro backdrop is still fundamentally hawkish, and traders should not mistake this morning’s yield dip for a trend change. September’s “Big Picture” was a bear flattener: the 2-year surged 53 bps and the 10-year 44 bps to its highest since 2007, driven by sticky inflation, high energy prices, heavy debt issuance, and a red-hot Atlanta Fed GDPNow Q3 estimate near 5.0%. Fed funds futures are pricing three more hikes before the April 2027 FOMC, with multiple officials teasing at least one more before year-end. The current target range sits at 3.75–4.00%, yet the 2-year yield at 4.79% is still screaming that more tightening is coming.
This morning’s full yield check: 2-yr -4 bps to 4.79%, 3-yr -5 bps to 4.91%, 5-yr -5 bps to 5.02%, 10-yr -5 bps to 5.26%, 30-yr -3 bps to 5.64%. Treasuries are trimming Monday’s losses, with the overnight bid helped by France’s OATs rallying off year-highs after Marine Le Pen floated EUR140 bln in spending cuts, and by the dismal German data. The U.S. Dollar Index is down 0.3% at 101.85; EUR/USD +0.5% to 1.1269, GBP/USD +0.4% to 1.3276. Gold is ripping +1.1% to ~$4,201 — a tell that inflation and debt concerns remain the dominant structural narrative beneath the equity optimism.
The key swing factor today is the 13:00 ET $58 bln 3-year note auction. With the front end so elevated, a soft auction could quickly reverse the morning’s yield relief and test whether equities can keep shrugging off rate pressure the way they did Monday. Geopolitically, improved Middle East crude flows and Yemen’s recapture of the Red Sea port of Mokha are easing the energy-inflation channel — the most constructive macro development for stocks right now.
Economic Calendar Today
- 8:30 AM ET — August Trade Balance: Consensus -$93.7B (Briefing) / -$89.0B (alt) | Prior -$88.6B. A widening deficit is a modest Q3 GDP drag; unlikely to move the tape unless far off.
- 1:00 PM ET — $58 bln 3-yr Treasury note auction: The real catalyst. Weak demand threatens the morning yield relief that is powering the equity bid.
- Earnings — Before open: LW (beat by $0.16, revs in-line, raised FY27 guide), APOG (beat by $0.58), RPM (beat by $0.03, missed revs, raised dividend 10.2%), NEOG.
- Earnings — After close: STZ (Constellation Brands) — the headline report; PENG, WS.
- No Fed speakers scheduled — the light calendar keeps rates and the auction in the driver’s seat.
Earnings & Corporate News
M&A is the dominant corporate theme. Option Care Health (OPCH) is gapping +19.8% after McKesson and CD&R agreed to acquire it for $32.05/share in cash. Uber is buying ezCater for $2.3 bln, KKR is acquiring Gen II Fund Services for $5.1 bln, Energy Transfer is taking Vaquero Midstream at ~$2.625 bln, and Emera agreed a $14.3 bln tie-up with Canadian Utilities. Monday’s deal action lingers too: PTC surged 33.5% to 192.26 on Schneider’s $205/share cash offer, while C.H. Robinson (CHRW -10.9%) got punished for overpaying in its $5.8 bln RXO acquisition — a reminder the tape is rewarding targets and penalizing acquirers taking on leverage.
On earnings, LW’s beat-and-raise is a constructive staples data point, and APOG’s $0.58 beat with fresh FY27 guidance stands out in materials. Vaxcyte (PCVX) is the biotech story — Monday’s OPUS-1 Phase 3 win for VAX-31 cleared a more stringent noninferiority bar than PCV20/PCV21, though shares are pulling back -2.8% this morning on a $500 mln stock/warrant plus $500 mln convertible raise. All eyes shift to STZ after the close.
Analyst flow skews constructive on cyclicals: BWA upgraded to Overweight at Morgan Stanley (tgt $95), CLF to Overweight at Wells Fargo, CTVA to Overweight at JPMorgan, and PG to Outperform at Evercore (tgt $166). On the bearish side, Nike (NKE) was cut to Sell at Berenberg (tgt $27.50) and Gentex to Sell at Goldman. Melius launched broad coverage on homebuilders with multiple Sell ratings (DHI, KBH, LEN, MTH) — a cautionary flag on rate-sensitive housing even as yields dip today.
WaveFinder Signal Summary
The scan environment is healthy, not euphoric. The Continuation/2LYNCH scan is firing 22 signals — a genuinely rich read that confirms the broadening thesis — clustered in MEDICAL (WAT, IDXX $527.07, TMO $676.76, MTD $1,541.63) and SOFTWARE (SHOP +5.8%, TEAM +4.7%). The Reversal scan is nearly empty at one signal (SWKS -1.3%), and there are no Delayed 9M setups today, so the edge is firmly on momentum continuation rather than bottom-fishing.
Breadth is the headline number: 23.93% of stocks above their 40-day SMA, up +2.3pp from 21.62%, while the 20-day measure exploded to 44% from 29%. That divergence — a fast-moving short-term reading against a still-depressed intermediate reading — tells you the rally is young and must prove it can lift the 40-day cohort before anyone declares an all-clear. Bulls lead bears 215 to 161 on the 4% gauge, a positive but not overwhelming tilt.
Today’s Watchlist
- SHOP — $160.11, +5.8% on a 2LYNCH continuation; software leadership, watch for follow-through above the gap on any broad-market strength.
- WAT — $440.12, +3.5% 2LYNCH with 1.4 RVOL; cleanest medical-sector momentum name, tight risk profile.
- GMAB — SIP leader at $38.48 on positive Phase 3 results, +9.6% from open, 4.43 RVOL; biot0ech catalyst with real volume behind it.
- OPCH — $28.27 pre-market, gapping +19.8% toward the $32.05 cash deal price; merger-arb watch, not a momentum chase.
- TMO — $676.76, +3.4% 2LYNCH; large-cap medical breakout confirming the sector rotation.
- STZ — reports after the close; T3A positioning ahead of the staples read, size accordingly into the print.
Action Codes of the Day
- CRT (Controlled Risk Taking) — With only 23.93% of names above the 40-day SMA but breadth expanding (+15pp on the 20-day), this is a choppy, early-recovery tape: take calculated risks within the system, size down, and let the 215-vs-161 bull edge work without overcommitting.
- T3A (Think 3 Days Ahead) — STZ tonight, LEVI/APLD Wednesday, PEP/HELE Thursday, DAL Friday, plus today’s $58 bln 3-yr auction at 13:00 ET — anticipate these catalysts and position for the reaction, not the headline.